¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦41Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2022-06-25

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦41Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2022-06-25
±³À°ÀÏÀÚ : 2022-06-25
±³À°Àå¼Ò : ºÎ»ê ½Ã±×´Ï¿¤ ±×·£µåº¼·ë(4F)  
±³À°ÁÖÁ¦ : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦41Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ
´ã´çÀÚ : Á¤ÀºÇý
¿¬¶ôó : 02-582-8212  
À̸ÞÀÏ : grace@kscvi.org      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 15 ½Ã°£ 55ºÐ  
¼¼ºÎ¼ö°­·á : 120,000¿ø      
ºñ°í - Àü¹®ÀÇ,°³¿øÀÇ,ÀϹÝÀÇ:(ÇöÀåµî·Ï)60,000¿ø - ÀüÀÓÀÇ,Àü°øÀÇ,°£È£»ç,ÀÇ·á±â»ç,ÀÇ´ë»ý,±ºÀÇ°ü,°øÁߺ¸°ÇÀÇ,ÀÓ»óº´¸®»ç,Àǹ«±â·Ï»ç:(ÇöÀåµî·Ï)50,000¿ø - »ê¾÷ü,±âŸ:(ÇöÀåµî·Ï)120,000¿ø - ÇÐȸ Á¤È¸¿ø(Àü³âµµ ȸºñ¿Ï³³ÀÚ): ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-25 Main Arena 09:00~09:10 TEER(Transcatheter Edge to Edge Repair) Including Primary MR(Mitral Regurgitation)  °­µµÀ±(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 09:10~09:20 Which Is Better: TEER(Transcatheter Edge to Edge Repair) vs TMVR(Transcatheter Mitral Valve Repair)?  Anita Asgar(Montreal Heart Institute. Canada) 
±³À°½Ã°£ 06-25 Main Arena 09:20~09:30 Anticoagulation after TAVR(Transcatheter Aortic Valve Replacement): Which Combination, How Many, How Long?  ±è¿øÀå(Â÷ÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 09:30~09:40 HALT(Hypoattenuated Leaflet Thickening): Foe or Fog?  Steven Bailey(LSU Health Shreveport. USA) 
Åä·Ð 06-25 Main Arena 09:40~10:00 Discussion  () 
±³À°½Ã°£ 06-25 Symposium Arena 09:00~09:15 Protruded LM(Left Main) Stent. No Turning Back? No, It Was Turned Back  ÀüÈ£¼º(¿øÁÖ¿¬¼¼ÀÇ´ë ¿øÁÖ¼¼ºê¶õ½º±âµ¶º´¿ø) 
±³À°½Ã°£ 06-25 Symposium Arena 09:15~09:30 Catch Me If You Can: A Long Journey for Retrieving Migrated Coronary Artery Stent into Tibial Artery  ±è»óÈ¿(ÀüºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 06-25 Symposium Arena 09:30~09:45 A Case of Repeated Stent Thrombosis after Primary PCI(Percutaneous Coronary Intervention) in Patient with Inferior STEMI(ST-elevation Myocardial Infarction) having Gastrointestinal Problem  ÀÌÈ¿Áø(°æ»ó´ëÇб³º´¿ø) 
±³À°½Ã°£ 06-25 Symposium Arena 09:45~10:00 Challenging Primary PCI(Percutaneous Coronary Intervention) with Complex Coronary Anatomy and Disease: Rocky Journey and Winding Road  ½ÅÀ±¹Î(Àü³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 06-25 Main Arena 10:10~10:55 Case 1 - CTO(Chronic Total Occlusion)  Àü±¹Áø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 10:55~11:40 Case 2 - Complex PCI(Percutaneous Coronary Intervention)  ÇÑÁÖ¿ë(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 10:10~10:30 AI ¾Ë°í¸®Áò ±â¹ÝÀÇ ÁßÀç½Ã¼ú µ¥ÀÌÅÍ °ü¸®  Á¶¼º¼ö(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 10:30~10:50 °øÅëµ¥ÀÌÅ͸𵨠(CDM, Common Data Model)À» È°¿ëÇÑ ¿¬±¸Àü·« ¼ö¸³°ú Àû¿ë  À¯½ÂÂù(¿¬¼¼ÀÇ´ë ¿¹¹æÀÇÇаú) 
±³À°½Ã°£ 06-25 Symposium Arena 10:50~11:10 ¿þ¾î·¯ºí ±â±â ±â¹Ý °³Àΰǰ­±â·ÏÀÇ È°¿ë  °­´ë¿ë(¿¬¼¼¿øÁÖÀÇ´ë Á¤¹ÐÀÇÇаú) 
Åä·Ð 06-25 Symposium Arena 11:10~11:40 Discussion  () 
±âŸ 06-25 Main Arena 12:00~12:05 Opening Remark  () 
±³À°½Ã°£ 06-25 Main Arena 12:05~12:25 ONYX ONE CLEAR 2yr Result - Asian Patient Subanalysis  °­ÁöÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 12:25~12:45 Resolute Onyx Bifurcation Case Sharing (Or Any Complex Case)  ÃÖÁ¤Ãµ(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 12:45~13:00 Discussion  () 
±³À°½Ã°£ 06-25 Symposium Arena 12:00~12:20 De-escalation Strategy in ACS(Acute Coronary Syndrome) Patients after PCI(Percutaneous Coronary Intervention)  ¹Ú°æ¿ì(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 12:20~12:40 Edoxaban versus Dual Antiplatelet Therapy for Leaflet Thrombosis and Cerebral Thromboembolism after TAVR(Transcatheter Aortic Valve Replacement)  °­µµÀ±(¿ï»êÀÇ´ë) 
Åä·Ð 06-25 Symposium Arena 12:40~13:00 Discussion  () 
±³À°½Ã°£ 06-25 Main Arena 13:10~13:55 Case 1 - º¹ºÎ´ëµ¿¸Æ·ù  ±èÁ¤¼ö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 13:55~14:40 Case 2 - Mitral Clip  ±èÁß¼±(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 13:10~13:25 Pivot-TR(Tricuspid Valve Regurgitation): A Novel Approach for Treating Tricuspid Regurgitation  ±èÁØÈ«(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 13:25~13:40 Strategy Performing Simultaneously Thrombus Aspiration/Ischemic Post-conditioning/Balloon Angioplasty using Multi-functional PTCA (Percutaneous Transluminal Coronary Angioplasty) Catheter in Patient with ST-segment Elevation Myocardial Infarction (STEMI)  À¯Ã¶¿õ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 13:40~13:55 PCI(Percutaneous Coronary Intervention) Toolbox Made in Korea  À±Ã¢È¯(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 13:55~14:10 Ç÷°üÁßÀç ½Ã¼úÀ» º¸Á¶ÇÏ´Â Àڱⱸµ¿Çü ¸¶ÀÌÅ©·Î ÀÇ·á·Îº¿ ½Ã½ºÅÛ (Robotically Assisted Magnetic Navigation System for Interventional Therapy)  Àå°ÇÈñ(ÇѾç°ø´ë ±â°è°øÇаú) 
Åä·Ð 06-25 Symposium Arena 14:10~14:40 Discussion  () 
±³À°½Ã°£ 06-25 Main Arena 14:50~15:05 Cardiogenic Shock with Multivessel Disease: Optimal Timing for Hemodynamic Support?  °­ÁöÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 15:05~15:20 Stumpless LAD(Left Anterior Descending Artery) CTO(Chronic Total Occlusion): Antegrade Approach or Retrograde Approach?  ³ëÁö¿õ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 15:20~15:35 Heavy Calcified Lesion: How to Obtain Enough Lumen Size without Risk?  ÃßÀºÈ£(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 15:35~15:50 Recurrent ISR(Intracoronary Stent Restenosis): How to Avoid Endless Loop, DCB(Drug-coated Balloon), DES(Drug-eluting Stent), or What Else?  ½ÅÀº¼®(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 14:50~15:03 New Pharmacological Management of Heart Failure with Reduced Ejection Fraction  Á¶ÇöÀç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 15:03~15:16 Revascularization of Ischemic Cardiomyopathy: When and How?  À̽Âȯ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 15:16~15:29 Cardiac Rehabilitation: Exercise and Education in Patients with Heart Failure  À±Á¾Âù(°¡Å縯ÀÇ´ë) 
Åä·Ð 06-25 Symposium Arena 15:29~15:50 Discussion  () 
±³À°½Ã°£ 06-25 Main Arena 16:00~16:20 How to Prevent Distal Limb Ischemia  À̽ÂÁØ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 16:20~16:40 How to Decrease LALeft Atrial) Pressure  ±è¹Îö(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 16:40~17:00 How to Prevent and Manage Harlequin Syndrome  Àå¿ìÁø(ÀÌÈ­ÀÇ´ë) 
±³À°½Ã°£ 06-25 Symposium Arena 16:00~16:12 Advantage of Transradial Access for ACS(Acute Coronary Syndrome)  Àå´ë¼®(¿ëÀμ¼ºê¶õ½ºº´¿ø) 
Åä·Ð 06-25 Symposium Arena 16:12~16:15 Discussion  () 
±³À°½Ã°£ 06-25 Symposium Arena 16:15~16:27 New Method of Two Stent Strategy for Bifurcation Lesion  ÃÖõÈñ(¼­¿ï¾Æ»êº´¿ø) 
Åä·Ð 06-25 Symposium Arena 16:27~16:30 Discussion  () 
±³À°½Ã°£ 06-25 Symposium Arena 16:30~16:42 Drug-coated balloon in Complex PCI(Percutaneous Coronary Intervention)  ¼Û°É¼ö(ºÐ´ç¼­¿ï´ëÇб³º´¿ø) 
Åä·Ð 06-25 Symposium Arena 16:42~16:45 Discussion  () 
±³À°½Ã°£ 06-25 Symposium Arena 16:45~16:57 OCT(Optical Coherence Tomography) Guided Rotational Atherectomy  ÀÓµµÇü(ÀÎõ¼º¸ðº´¿ø) 
Åä·Ð 06-25 Symposium Arena 16:57~17:00 Discussion  () 
±³À°½Ã°£ 06-25 Main Arena 17:10~17:20 Non-native Vessel (Bypass Graft or LIMA(Left Internal Mammary Artery)) Intervention Tip  ÃÖÀ±¼®(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 17:20~17:30 Right & Left Hemodynamic Assessment  ±èÁö¹Ú(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 17:30~17:40 Wire & Balloon Ư¼º ÀÌÇØ  ¾ÈÁ¤¹Î(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-25 Main Arena 17:40~17:50 DES(Drug-eluting Stent) Technology: DES(Drug-eluting Stent) Á¾·ùº° Ư¼º  ½ÉµÎ¼±(Àü³²ÀÇ´ë) 
Åä·Ð 06-25 Main Arena 17:50~18:10 Discussion  () 
±³À°½Ã°£ 06-25 Symposium Arena 17:10~17:20 Cases with Good Results Using Real-time IVUS(Intravascular Ultrasonography) in LAD(Left Anterior Descending Artery) CTO(Chronic Total Occlusion) PCI  ÀÌÂùÈñ(°è¸í´ëÇб³ µ¿»êº´¿ø) 
±³À°½Ã°£ 06-25 Symposium Arena 17:20~17:30 Best & Worst Case of PCI(Percutaneous Coronary Intervention)  ¹ÚÀα¸(°æºÏ´ëÇб³º´¿ø) 
Åä·Ð 06-25 Symposium Arena 17:30~17:40 Discussion  () 
±³À°½Ã°£ 06-25 Symposium Arena 17:40~17:50 Intramural Hematoma during the CTO(Chronic Total Occlusion) Intervention  ½ÅÈ¿¿ø(¼¼ºê¶õ½º ½ÉÀåÇ÷°üº´¿ø) 
±³À°½Ã°£ 06-25 Symposium Arena 17:50~18:00 Transaortic TAVR(Transcatheter Aortic Valve Replacement) Procedure  À̱Ⳳ(°í·Á´ëÇб³ ¾È¾Ïº´¿ø) 
Åä·Ð 06-25 Symposium Arena 18:00~18:10 Discussion  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ Á¦41Â÷ ÇÏ°è±¹Á¦Çмú´ëȸ (2ÀÏÂ÷) : 2022-06-25""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2022 ´ëÇÑÃéÀå´ãµµÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Pancreas-Biliary Single topic symposium : 2022-06-25
´ÙÀ½±Û 2022 ´ëÇѳëÀοä¾çºñ´¢ÀÇÇÐȸ Á¦5Â÷ Á¤±âÇмú´ëȸ : 2022-06-25
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20467 ¼­¿ï 2024 ´ëÇÑÇ÷¾×ÇÐȸ Á¶Á÷±¸Áõ½ÄÁõ¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-31 0 76 2024-04-17
20466 °æ±â ¾ÆÁִ뺴¿ø ÀÀ±ÞÀÇÇаú ¼³¸³ 30Áֳ⠱â³ä ½ÉÆ÷Áö¿ò : 2024-05-30 0 39 2024-04-17
20465 ¼­¿ï Á¦20Â÷ ´ëÇѸð¹ßÇÐȸ Çмú´ëȸ ÇÁ·Î±×·¥ : 2024-05-26 0 46 2024-04-17
20464 °æ±â 2024³â Á¦86Â÷ ´ëÇÑ»ý½ÄÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-26 0 35 2024-04-17
20463 ¼­¿ï 2024³â ´ëÇѼҾƼÒÈ­±â¿µ¾çÇÐȸ Ãá°è ½ÉÆ÷Áö¾ö : 2024-05-26 0 26 2024-04-17
20462 ¼­¿ï ´ëÇÑÃæ°ÝÆÄÄ¡·áÇÐȸ 2024 Ãá°è Çмú´ëȸ : 2024-05-26 0 26 2024-04-17
20461 ¼­¿ï Áø´Ü ü°èÀû¹®Çå°íÂû ¿öÅ©¼¥ : 2024-05-25 0 30 2024-04-17
20460 ¼­¿ï ´ëÇѺñ¸¸ÇÐȸ Á¦17ȸ ODOT (One Day Course of Obesity Treatment) : 2024-05-25 0 24 2024-04-17
20459 ¼­¿ï 2024³â Á¾¾ç¸é¿ª´ÙÇÐÁ¦¿¬±¸È¸ Ãá°è½ÉÆ÷Áö¾ö : 2024-05-24 0 16 2024-04-17
20458 ¼­¿ï 2024 Á¦12ȸ ´ëÇÑÇ÷¾×ÇÐȸ Ç÷¿ìº´¿¬±¸È¸ ½ÉÆ÷Áö¾ö : 2024-05-24 0 28 2024-04-17
20457 ¼­¿ï 2024³â ¿µµîÆ÷±¸ÀÇ»çȸ Ãá°è Çмú´ëȸ : 2024-05-21 0 32 2024-04-17
20456 ¼­¿ï 2024³â ´ëÇÑÀÓ»ó°Ç°­ÁõÁøÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-19 0 35 2024-04-17
20455 ¼­¿ï Á¦7Â÷ ´ëÇѼö¸éÈ£ÈíÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-19 0 41 2024-04-17
20454 ¼­¿ï 2024 ´ëÇѼҾÆÇ÷¾×Á¾¾çÇÐȸ Ãá°è¿¬¼ö°­Á : 2024-05-18 0 26 2024-04-17
20453 ¼­¿ï 2024³â ´ëÇÑ¿¬ÇÏÀå¾ÖÇÐȸ Á¦14ȸ Ãá°èÇмú´ëȸ : 2024-05-18 0 31 2024-04-17
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷